Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124

Man’s best friend could play a pivotal role beyond companionship. Recent research from the University of Bristol reveals that trained dogs may have the ability to detect Parkinson’s disease long before symptoms manifest.
Previous studies established that individuals with Parkinson’s have increased sebum, an oily and waxy substance, on their skin that emits a distinct musky odor. This discovery sparked further investigation into whether dogs could use their acute sense of smell to identify the disease.
In the latest study, two trained dogs — a golden retriever named Bumper and a black Labrador named Peanut — were subjected to tests involving over 200 odor samples. They were presented with skin swabs from 130 individuals diagnosed with Parkinson’s disease and 175 healthy participants, according to the findings published in The Journal of Parkinson’s Disease on July 15.
The dogs successfully identified skin samples from Parkinson’s patients with a sensitivity rate of up to 80 percent. This impressive figure signifies that they correctly detected disease presence approximately four out of five times. Additionally, they demonstrated specificity of up to 98 percent, effectively ruling out the majority of samples from individuals without the disease.
This study was a collaborative effort between the University of Bristol, Medical Detection Dogs, and the University of Manchester. Lead study author Nicola Rooney, an associate professor at Bristol Veterinary School, emphasized the importance of their findings.
“Identifying diagnostic biomarkers of Parkinson’s disease, especially those that can predict onset or assist in early diagnosis, is the focus of ongoing research,” Rooney explained in a press release. She went on to highlight that the results show dogs possess an olfactory signature unique to Parkinson’s patients.
“Sensitivity levels of 70 to 80 percent are significantly better than chance,” she noted. Rooney believes that dogs could contribute to developing a quick, non-invasive, and cost-effective method for identifying individuals with Parkinson’s disease.
Claire Guest, chief scientific officer at Medical Detection Dogs in the U.K., reiterated that the results affirm dogs’ remarkable capacity to detect disease with high accuracy. She stated, “Timely diagnosis is crucial, as subsequent treatment can slow the disease’s progression and alleviate symptoms intensity,” further illustrating the potential impact of this research.
Perdita Barran, a professor of mass spectrometry at the University of Manchester, added her perspective on the study’s implications. She remarked that the research enriches the growing body of evidence demonstrating that simple, non-invasive skin swabs can assist in diagnosing Parkinson’s disease, promoting faster and more accessible early detection.
As the dog detection capacities for early-stage Parkinson’s disease detection are explored, the research team intends to conduct longer-term studies. These studies aim to further assess the dogs’ efficacy in identifying Parkinson’s prior to traditional clinical diagnosis methods.
The funding for this innovative study was generously provided by the Michael J. Fox Foundation and Parkinson’s UK, organizations dedicated to Parkinson’s disease research and awareness.
This groundbreaking research may open up new avenues for early detection and intervention, potentially improving quality of life for many individuals predisposed to or already living with Parkinson’s disease.
As the understanding of Parkinson’s disease continues to evolve, the possibility that man’s best friend can help in the medical field encourages unique collaborations between veterinary sciences and healthcare research.